Multi-modal profiling of human fetal liver hematopoietic stem cells reveals the molecular signature of engraftment.
Saved in:
| Title: | Multi-modal profiling of human fetal liver hematopoietic stem cells reveals the molecular signature of engraftment. |
|---|---|
| Authors: | Vanuytsel K; Section of Hematology and Medical Oncology, School of Medicine, Boston University, Boston, MA, USA. kimvan@bu.edu.; Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA. kimvan@bu.edu., Villacorta-Martin C; Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA., Lindstrom-Vautrin J; Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA., Wang Z; Division of Computational Biomedicine, School of Medicine, Boston University, Boston, MA, USA., Garcia-Beltran WF; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Vrbanac V; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Parsons D; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Lam EC; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Matte TM; Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA., Dowrey TW; Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA., Kumar SS; Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA., Li M; Division of Computational Biomedicine, School of Medicine, Boston University, Boston, MA, USA., Wang F; Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA., Yeung AK; Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA., Mostoslavsky G; Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA., Dries R; Section of Hematology and Medical Oncology, School of Medicine, Boston University, Boston, MA, USA.; Division of Computational Biomedicine, School of Medicine, Boston University, Boston, MA, USA., Campbell JD; Division of Computational Biomedicine, School of Medicine, Boston University, Boston, MA, USA., Belkina AC; Department of Pathology and Laboratory Medicine, School of Medicine, Boston University, Boston, MA, USA.; Flow Cytometry Core Facility, School of Medicine, Boston University, Boston, MA, USA., Balazs AB; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA. abalazs@mgh.harvard.edu., Murphy GJ; Section of Hematology and Medical Oncology, School of Medicine, Boston University, Boston, MA, USA. gjmurphy@bu.edu.; Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA. gjmurphy@bu.edu. |
| Source: | Nature communications [Nat Commun] 2022 Mar 01; Vol. 13 (1), pp. 1103. Date of Electronic Publication: 2022 Mar 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-022-28616-x |
